1-4 of 4
Yan Shi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors

Free
Julie L. Wilsbacher, Min Cheng, Dong Cheng, Samuel A.J. Trammell, Yan Shi, Jun Guo, Stormy L. Koeniger, Peter J. Kovar, Yupeng He, Sujatha Selvaraju, H. Robin Heyman, Bryan K. Sorensen, Richard F. Clark, T. Matthew Hansen, Kenton L. Longenecker, Diana Raich, Alla V. Korepanova, Steven Cepa, Danli L. Towne, Vivek C. Abraham, Hua Tang, Paul L. Richardson, Shaun M. McLoughlin, Ilaria Badagnani, Michael L. Curtin, Michael R. Michaelides, David Maag, F. Gregory Buchanan, Gary G. Chiang, Wenqing Gao, Saul H. Rosenberg, Charles Brenner, Chris Tse
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (7): 1236–1245.
https://doi.org/10.1158/1535-7163.MCT-16-0819
Published: 04 July 2017
View articletitled, Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Open the PDF for Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract A161: Acquired resistance to combination treatment with TMZ and ABT‐888 is mediated by both BER and HR DNA repair pathways

Free
Xuesong Liu, Edward K. Han, Mark G. Anderson, Yan Shi, Dimitri Semizarov, Gang Wang, Thomas McGonigal, Lisa Roberts, Ioren Iasko, Joann Palma, Gui‐Dong Zhu, Thomas Penning, Saul Rosenberg, Vincent Giranda, Yan Luo, Joel Leverson, Eric F. Johnson, Alexander R. Shoemaker
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A161.
https://doi.org/10.1158/1535-7163.TARG-09-A161
Published: 10 December 2009
View articletitled, Abstract A161: Acquired resistance to combination treatment with TMZ and ABT‐888 is mediated by both BER and HR DNA repair pathways
Journal Articles

Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis

Free
Xuesong Liu, Yan Shi, Vincent L. Giranda, Yan Luo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 494–501.
https://doi.org/10.1158/1535-7163.MCT-05-0049
Published: 16 March 2006
View articletitled, Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis
Open the PDF for Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis in another window
Journal Articles

Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo

Free
Yan Luo, Alexander R. Shoemaker, Xuesong Liu, Keith W. Woods, Sheela A. Thomas, Ron de Jong, Edward K. Han, Tongmei Li, Vincent S. Stoll, Jessica A. Powlas, Anatol Oleksijew, Michael J. Mitten, Yan Shi, Ran Guan, Thomas P. McGonigal, Vered Klinghofer, Eric F. Johnson, Joel D. Leverson, Jennifer J. Bouska, Mulugeta Mamo, Richard A. Smith, Emily E. Gramling-Evans, Bradley A. Zinker, Amanda K. Mika, Phong T. Nguyen, Tilman Oltersdorf, Saul H. Rosenberg, Qun Li, Vincent L. Giranda
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (6): 977–986.
https://doi.org/10.1158/1535-7163.MCT-05-0005
Published: 14 June 2005
View articletitled, Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo
Open the PDF for Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo in another window